drugset / Trial / NCT00968045

Fibrinogen and Bleeding After Cardiac Surgery

NCT00968045

Phase 2 Completed 52 enrolled Sahlgrenska University Hospital
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The study hypothesis is that prophylactic fibrinogen infusion reduces postoperative bleeding and transfusion requirements after coronary artery bypass surgery (CABG) in patients with endogenous fibrinogen levels in the lower normal range. 60 patients will be included in a prospective, randomized double-blind placebo-controlled single center study.

Timeline

Start
2009-04
Primary completion
2012-02
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic 2 g